Osteofibrous Dysplasia and Adamantinoma: Correlation of Proto-Oncogene Product and Matrix Protein Expression

Human Pathology

Volumn 35, Issue 1, 2004, Pages 69-74

  Maki, Masahiiko ^a   Athanasou, Nicholas ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adamantinoma; Matrix protein; Oncogene; Osteofibrosis dysplasia

Indexed keywords

COLLAGEN TYPE 4; GALECTIN 3; GENE PRODUCT; LAMININ; LAMININ BINDING PROTEIN; MATRIX PROTEIN; NERVE CELL ADHESION MOLECULE; ONCOPROTEIN; OSTEOCALCIN; OSTEONECTIN; PROTEIN C JUN; TRANSFORMING GROWTH FACTOR; UVOMORULIN;

ADOLESCENT; ADULT; AMELOBLASTOMA; ARTICLE; BONE DYSPLASIA; CELL DIFFERENTIATION; CELL ULTRASTRUCTURE; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYME; ONCOGENE C FOS; ONCOGENE C MET; OSTEOFIBROUS DYSPLASIA; PROTEIN EXPRESSION; PROTO ONCOGENE;

EID: 1642499132     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2003.07.008     Document Type: Article

References (29)

1. Unni KK: Dahlin's Bone Tumors: General Aspects and Data on 11,087 Cases, ed 5. Philadelphia, PA, Lippincott-Raven, 1996
2. Campanacci M, Laus M: Osteofibrous dysplasia of the tibia and fibula. J Bone Joint Surg Am 63A:367-375, 1981
3. Czerniak B, Rojas-Corona RR, Dorfman HD: Morphologic diversity, of long bone adamantinoma. The concept of differentiated (regressing) adamantinoma and its relationship to osteofibrous dysplasia. Cancer 64:2319-2334, 1989
4. Benassi MS, Campanacci L, Gamberi G, et al: Cytokeratin expression and distribution in adamantinoma of the long bones and osteofibrous dysplasia of the tibia and fibula: An immunohistochemical study correlated to histogenesis. Histopathology 25:71-73, 1994
5. Ishida T, Iijima T, Kikuchi F, et al: A clinicopathological and immunohistochemical study of osteofibrous dysplasia, differentiated adamantinoma and adamantinoma of long bones. Skeletal Radiol 21:493-502, 1992
6. Maki M, Saitoh K, Kaneko Y, et al: Expression of cytokeratin 1, 5, 14, 19 and transforming growth factors-B1, B2, B3 in osteofibrous dysplasia and adamantinoma: A possible association of transforming growth factor-β with basal cell phenotype promotion. Pathol Int 50:801-807, 2000
7. Springfield DS, Rosenberg AE, Mankin HJ, et al: Relationship between osteofibrous dysplasia and adamantinoma. Clin Orthop 309: 234-244, 1994
8. Hazelbag HM, Taminiau AHM, Fleuren GJ, et al: Adamantinoma of the long bones: A clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion and biological behavior. J Bone Joint Surg Am 76:1482-1499, 1994
9. Franchi A, Calzolari A, Zampi G: Immunohistochemical detection of c-fos and c-jun expression in osseous and cartilaginous tumors of the skeleton. Virchows Arch 432:515-519, 1998
10. Grigoriadis AE, Wang ZL, Wagner E: Regulation of bone cell differentiation by the c-Fos/AP-1 transcription factor, in Bilezikian J, Raisz LG, Rodan GA (eds): Principles of Bone Biology. New York, Academic Press, 1996, pp 15-24
11. Lian JB, Stein GS, Canalis E, et al: Bone formation: Osteoblast lineage cells, growth factors, matrix proteins and the mineralization process, in Favus MJ (ed): Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Philadelphia, PA, Lippincott Williams & Wilkins, 1999, pp 14-30
12. Sakamoto A, Oda Y, Iwamoto Y, et al: A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to expression of c-fos and c-jun products and bone matrix proteins: A clinicopathologic review and immunohistochemical study of c-fos, c-jun, type 1 collagen, osteonectin, osteopontin, and osteocalcin. HUM PATHOL 30:1418-1426, 1999
13. Yan J, Liajia Y: The relationship between bone morphogenetic protein and neoplastic bone diseases. Clin Orthop 259:233-238, 1990
14. Fanburg JC, Rosenburg AE, Weaver DL, et al: Osteocalcin and osteonectin immunoreactivity in the diagnosis of osteosarcoma. Am J Clin Pathol 108:464-473, 1997
15. Hazelbag HM, Van den Broek LJ, Fleuren GJ, et al: Distribution of extracellular matrix components in adamantinoma of long bones suggests fibrous-to-epithelial transformation. HUM PATHOL 28: 183-188, 1997
16. Ekblom P: Developmentally regulated conversion of mesenchyme to epithelium. FASEB J 3:2141-2150, 1989
17. Tsarfaty, I, Rong S, Resau JH, et al: The Met proto-oncogene mesenchymal to epithelial cell conversion. Science 263:98-101, 1994
18. Arenas MI, Romo E, Royuela M, et al: E-, N-, and P-cadherin, and alfa-, beta-, and gamma-catenin protein expression in normal, hyperplastic, and carcinomatous human prostate. Histochem J 32: 659-667, 2000
19. Franza RB Jr, Rauscher FJ III, Josephs SF, et al: The Fos complex and Fos-related antigens recognize sequence elements that contain AP-1 binding sites. Science 239:1150-1153, 1988
20. Guarino M, Squillaci S, Reale D, et al: The basement membranes in sarcomatoid carcinomas: An immunohistochemical study. Tumori 79:128-132, 1993
21. Guarino M, Christensen L: Immunohistochemical analysis of extracellular matrix components in synovial sarcoma. J Pathol 172: 279-286, 1994
22. Fernandez PL, Merino MJ, Gomez M, et al: Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol 181:80-86, 1997
23. Motoi T, Ishida T, Kuroda M, et al: Coexpression of hepatocyte growth factor and c-Met proto-oncogene product in synovial sarcoma. Pathol Int 48:769-775, 1998
24. Sato H, Hasegawa T, Abe Y, et al: Expression of E-cadherin in bone and soft tissue sarcomas: A possible role in epithelial differentiation. HUM PATHOL 30:1344-1349, 1999
25. Naka T, Oda Y, Iwamoto Y, et al: Immunohistochemical analysis of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin, and neural cell adhesion molecule (NCAM) in chordoma. J Clin Pathol 54:945-950, 2001
26. Takeichi M: The cadherins: Cell-cell adhesion molecules controlling animal macrophages. Development 102:639-655, 1998
27. Vleminckx K, Vakaet L Jr, Mareel MM, et al: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66:107-119, 1991
28. Smith MEF, Brown JI, Fisher C: Epithelioid sarcoma: Presence of vascular-endothelial cadherin and lack of epithelial cadherin. Histopathology 33:425-431, 1998
29. Matsui Y, Nakata K, Araki N, et al: Alternative splicing of fibronectin transcriptsis in osteochondrogenic tumor. Anticancer Res 21:1103-1106, 2001